What are the commercial determinants of cancer control policy?



Published
Wednesday 27 April 2022, 12:00-13:00 CET

Cancer is a major health, social and public policy challenge and successfully tackling it requires an understanding of all its determinants. Although commercial determinants are a relatively new field of study, there are emerging themes which are very important for cancer policy and the cancer control continuum.
Commercial determinants are those private-sector activities that affect the health of populations, but this is often neglected due to commercial interests often trumping nobler health goals.
So, what are the commercial determinants of cancer control policy? What are the challenges and opportunities for governing them along the cancer control continuum? Join us to find out!

Keynote:
Marilys Corbex, World Health Organization, Regional Office for Europe
Monika Kosinska, World Health Organization, HQ

Speakers:
Gauden Galea, World Health Organization Representative Office in China
Stuart Hogarth, University of Cambridge
Richard Sullivan, Kings College London

Moderators:
Matthias Wismar & Erica Richardson, European Observatory on Health Systems and Policies

@OBShealth #OBSwebinars

We would like to recognise the contribution of those who led the related Eurohealth Special Issue, including:

Special Guest Editors:
Tit Albreht, National Institute of Public Health of Slovenia and the Faculty of Medicine, University of Ljubljana, Slovenia
Marilys Corbex, World Health Organization, Regional Office for Europe, Copenhagen, Denmark
Monika Kosinska, World Health Organization, Geneva, Switzerland
Jose M. Martin-Moreno, Medical School and INCLIVA, Clinical Hospital, University of Valencia, Spain

Eurohealth Editors:
Sherry Merkur, European Observatory on Health Systems and Policies, London, UK
Gemma A Williams, European Observatory on Health Systems and Policies, London, UK
Category
Management
Be the first to comment